Mistakes made at Copenhagen may get repeated at Doha climate talks

Qatar could ask ministers to short-circuit negotiations

Science and Technology - Briefs

New EIA process stumbles at start

News 360° - Briefs

Big pharma’s dirty tricks

Drug giants from GSK, Abbott and Pfizer to Bayer have been fined for serious malpractices. They should be under close watch in India

Up for scrutiny

Environment ministry sets up certification scheme for its forests

Disclosure-shy industry

Pharma and biotech firms are lobbying hard to block disclosure of origin of genetic material used in inventions, but they also raise thorny issues

WTO gives India a clean chit

Apex trade regulator finds nothing amiss in India's intellectual property laws after exhaustive review

US-China climate deal: Maker or breaker?

Rising sea levels prompt South Florida to demand statehood

The rising levels threaten to submerge living spaces, national parks and a nuclear reactor site

World Bank won't fund Luhri hydropower project in Himachal

Move to withdraw US $ 650 million follows inspection and review by USAID of environmental and social impacts of the project

One step forward, two steps back

Countries want to do little to keep global average temperature rise to below 2oC. The Warsaw climate talks have exposed this. A report by Uthra …

Science and Technology - Briefs

Science and Technology - Briefs

Science and Technology - Briefs

As green as billed?

Science and Technology - Briefs

News 360° - Briefs

What is healthy oil for our healthy bodies

Equity: the next frontier in climate talks

Not rebuilding for tomorrow

The Bhopal legacy: reworking corporate liability

Loud and unclear

Ethics on trial

Five per cent of the clinical trials conducted across the world will be in India by 2012. They are vital for confirming the efficacy of a new drug,…

Science and Technology - Briefs